Advanced alcoholic liver disease driven by a proferroptotic diet
Journal of Lipid Research · 2025
DOI: 10.1016/j.jlr.2025.100898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Yonggang Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Thoracic Surgery, The Second Affili…. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Ferroptosis, Diet. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Alcoholic liver disease (ALD) encompasses a spectrum of disorders, with advanced ALD-characterized by liver fibrosis-representing a severe stage with high mortality. The National Institute on Alcohol Abuse and Alcoholism ALD mouse model, a classical approach to studying ALD by delivering alcohol through the Lieber-DeCarli (LD) diet, typically does not progress to advanced ALD. We previously determined that ferroptosis causes hepatocellular injury in this model. Here, we speculate that the enrichment of MUFAs and vitamin E, which inhibit ferroptosis, and the lack of the proferroptotic nutrient iron in the LD diet may limit the progression of ALD by inhibiting ferroptosis. To test this hypothesis, we modified the LD diet to generate a proferroptotic LD (PFLD) diet by depleting vitamin E, increasing dietary levels of iron, and replacing MUFAs with PUFAs that drive ferroptosis. Upon feeding alcohol through the PFLD diet, ∼30% of the mice developed liver fibrosis and macrosteatosis, hallmarks of advanced ALD. These pathological changes were associated with exacerbated ferroptosis, possibly driven by overaccumulation of PUFA-containing triglycerides. Our findings underscore the critical role of dietary lipid composition in determining ALD severity, and demonstrate that feeding alcohol through the PFLD diet may serve as a mouse model for advanced ALD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- College of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- Huazhong Agricultural University
- National Institute of General Medical Sciences
Zitieren
APA
Liang, Y., Xu, Y., Virostek, M., Johnson, A., Evers, B., Deng, Y., Meng, Y., McDonald, J. G., Scherer, P. E., Cui, S., & Ye, J. (2025). Advanced alcoholic liver disease driven by a proferroptotic diet. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100898
Vancouver
Liang Y, Xu Y, Virostek M, Johnson A, Evers B, Deng Y, et al. Advanced alcoholic liver disease driven by a proferroptotic diet. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100898
BibTeX
@article{Liang2025,
author = {Liang, Yonggang and Xu, Yanchao and Virostek, Megan and Johnson, Ann and Evers, Bret and Deng, Yaqin and Meng, Yawen and McDonald, Jeffrey G and Scherer, Philipp E and Cui, Shaojie and Ye, Jin},
title = {Advanced alcoholic liver disease driven by a proferroptotic diet},
journal = {Journal of Lipid Research},
year = {2025},
doi = {10.1016/j.jlr.2025.100898}
}
EUVIMED